Relief Therapeutics Holding AG (RLFTF): Aviptadil does seem to be a genuinely ef...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	22
Posts	1818
Boards Moderated	0
Alias Born	07/12/2003

elllk

Re: None

Wednesday, 01/12/2022 10:49:26 AM

Wednesday, January 12, 2022 10:49:26 AM

Aviptadil does seem to be a genuinely effective treatment for COVID19. It is also cheap to produce. With COVID19 continuing to spread the need is clearly there and could easily be implemented. The reward for investors would be great.

Could the current legal battle between Relief and Neuro be tolerable for the companies for the time being because it allows insiders to buy more at a cheap price before good news is announced. The problems could be easily and quickly resolved. That, for instance, could be done overnight by a buyout.

We have not here heard much about the Owens and Minor buyout of Relief Therapeutics formerly (I am not sure of the current status) wholly owned subsidiary Applied Pharma Research (APR ) which has been developing Relief's Sentinox Nasal Spray. Could that be the first step towards a Relieftherapeutics (and maybe also Neuro) buyout?